PPP1R15A and idiopathic pulmonary fibrosis: In light of our novel findings, we speculate that the restoration of PPP1R15A activity in lung fibroblasts might represent an attractive therapeutic approach that interrupts the relentless deposition of extracellular matrix in IPF.